top of page

Presentation: 2024 ND EPSCoR Annual conference 

November 21, 2024, Alerus Center, Grand Forks, North Dakota

Rapid Synthesis of N-[1-(4-iodophenyl)ethyl]formamide

Kellie

Izydorek

Undergraduate Student
Minot State University

Co-authors: Mikhail Bobylev, PhD, Minot State University; Lioudmila I. Bobyleva, MS, Minot State University

Session

Poster Session A

Poster #32

Background: Earlier, we developed a rapid procedure for the Leuckart reaction and successfully applied it for the synthesis of substituted N-(1-phenylethyl)formamides. Specifically, the reaction between 4-bromoacetophenone and unsubstituted formamide was completed in 15 minutes and produced N-[1-(4-bromophenyl)ethyl]formamide with an isolated yield of 75%. The new procedure appeared to be much faster than the traditional Leuckart reaction that is usually completed within 3 to 6 hours. Hypothesis: Bromine is a moderately electron-withdrawing group. It reduces the electron density on the carbonyl and makes it more reactive towards formamide in the Leuckart reaction. Replacing bromine with iodine, a less electron-withdrawing group, will make the carbonyl slightly less reactive and slow down the Leuckart reaction. In this work, the hypothesis was tested in the reaction between 4-iodoacetophenone and formamide. Methods: The reaction was conducted on a 5 mmol scale at 180ºC - 202ºC. Extraction and column chromatography were used for the isolation of the products of the reaction. NMR-spectroscopy and elemental analysis were used to determine the structures of the products. Result: The reaction was completed in 10 minutes and produced N-[1-(4-iodophenyl)ethyl]formamide in good yield. Conclusion: The reaction with 4-iodoacetophenone was completed even faster than the reaction with 4-bromoacetophenone because of the higher boiling temperature of the reaction mixture. N-[1-(4-iodophenyl)ethyl]formamide is a new compound. Support: Research presented in this presentation was supported by NIH grant 8 P20 GM103442-12 from the National Institute of General Medical Sciences and by the National Science Foundation under NSF EPSCoR Track-1 Cooperative Agreement OIA #1946202

The ND-ACES NSF Track-1 cooperative agreement is a federal-state partnership to manage a comprehensive research development plan. ND EPSCoR manages the Track-1 award. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. Current funding is provided by the State of North Dakota and NSF EPSCoR Research Infrastructure Improvement Program Track-1 (RII Track-1) Cooperative Agreement Award OIA #1946202. 

bottom of page